Use of Johnson & Johnson’s JNJ -0.57% vaccines could resume as soon as this weekend after U.S. health regulators lifted the pause on the shots Friday evening. J&J and regulators plan to add language to the vaccine’s label warning of a risk of blood clots.

“This should be reassuring, because it’s in our country’s interest to vaccinate as many people as possible, yet the FDA has acted promptly to pause until we know more,” says Vivek Cherian, an internal medicine physician at the University of Maryland health-care system.

Dr. Vivek Cherian, an internal medicine physician in Baltimore, said to pay attention to your body post-vaccine.

"Instead of taking away confidence from other vaccines, this should actually inspire further confidence in the oversight of these vaccines and definitely should not deter individuals scheduled for either Pfizer and Moderna vaccines to go through with their appointments," Dr. Vivek Cherian, an internal-medicine physician in Baltimore, told Insider.

Dr. Vivek Cherian M.D., an internal medicine physician, tells Bustle that out of hundreds of patients with COVID he’s treated in the past year, only two had this symptom. Both patients got the tingling as a result of a COVID diagnosis, not a vaccine, and both happened to have an autoimmune condition.

The CDC and FDA made the recommendation in order to investigate reports of potentially dangerous blood clots.